As of Nov 27
| +0.12 / +5.15%|
The 5 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 11.00 and a low estimate of 4.00. The median estimate represents a +104.08% increase from the last price of 2.45.
The current consensus among 7 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.